Although the effect of BCA2 on NF-κB in non-tumor breast cells was unexpected, the contrasting effects that BCA2 exerts on IRF1 made us hypothesize that this distinct regulation might help explain the current controversies on the role of BCA2 in cancer development. The gene discussed is NFKB1; the disease is neoplasm.